Tower Research Capital (TRC)’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40K | Sell |
11,565
-404
| -3% | -$1.4K | ﹤0.01% | 3163 |
|
|
2025
Q1 | $31.4K | Sell |
11,969
-15,159
| -56% | -$39.7K | ﹤0.01% | 2575 |
|
|
2024
Q4 | $112K | Buy |
27,128
+6,078
| +29% | +$25K | ﹤0.01% | 2090 |
|
|
2024
Q3 | $149K | Sell |
21,050
-1,190
| -5% | -$8.43K | ﹤0.01% | 1900 |
|
|
2024
Q2 | $145K | Buy |
22,240
+21,829
| +5,311% | +$142K | ﹤0.01% | 2318 |
|
|
2024
Q1 | $3.41K | Sell |
411
-16,989
| -98% | -$141K | ﹤0.01% | 4869 |
|
|
2023
Q4 | $192K | Buy |
17,400
+15,136
| +669% | +$167K | ﹤0.01% | 2134 |
|
|
2023
Q3 | $19K | Sell |
2,264
-8,098
| -78% | -$68.1K | ﹤0.01% | 3422 |
|
|
2023
Q2 | $130K | Buy |
10,362
+5,872
| +131% | +$73.8K | ﹤0.01% | 1853 |
|
|
2023
Q1 | $74K | Sell |
4,490
-5,916
| -57% | -$97.5K | ﹤0.01% | 2151 |
|
|
2022
Q4 | $156K | Buy |
10,406
+1,245
| +14% | +$18.7K | 0.01% | 1483 |
|
|
2022
Q3 | $205K | Sell |
9,161
-6,020
| -40% | -$135K | ﹤0.01% | 1913 |
|
|
2022
Q2 | $254K | Buy |
15,181
+12,473
| +461% | +$209K | 0.01% | 1604 |
|
|
2022
Q1 | $81K | Sell |
2,708
-4,901
| -64% | -$147K | ﹤0.01% | 2370 |
|
|
2021
Q4 | $234K | Sell |
7,609
-1,131
| -13% | -$34.8K | ﹤0.01% | 1637 |
|
|
2021
Q3 | $276K | Buy |
8,740
+5,103
| +140% | +$161K | 0.01% | 1500 |
|
|
2021
Q2 | $134K | Sell |
3,637
-20
| -0.5% | -$737 | ﹤0.01% | 2192 |
|
|
2021
Q1 | $126K | Sell |
3,657
-3,427
| -48% | -$118K | ﹤0.01% | 2402 |
|
|
2020
Q4 | $295K | Buy |
7,084
+1,960
| +38% | +$81.6K | 0.01% | 1406 |
|
|
2020
Q3 | $218K | Buy |
+5,124
| New | +$218K | ﹤0.01% | 2499 |
|